Alerts will be sent to your verified email
Verify Email
VINEETLAB
|
Vineet Laboratories
|
Medistep Healthcare
|
Sandu Pharmaceutical
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-20.75 % | 24.77 % | 3.72 % |
|
5yr average Equity Multiplier
|
4.27 | 1.32 | 1.33 |
|
5yr Average Asset Turnover Ratio
|
1.52 | 2.13 | 1.23 |
|
5yr Avg Net Profit Margin
|
-4.28 % | 8.79 % | 2.27 % |
|
Price to Book
|
2.53 | 2.14 | 0.88 |
|
P/E
|
0.0 | 8.57 | 23.66 |
|
5yr Avg Cash Conversion Cycle
|
179.8 Days | 115.71 Days | 48.49 Days |
|
Inventory Days
|
114.74 Days | 9.08 Days | 74.6 Days |
|
Days Receivable
|
109.14 Days | 124.47 Days | 26.14 Days |
|
Days Payable
|
115.29 Days | 17.5 Days | 72.73 Days |
|
5yr Average Interest Coverage Ratio
|
1.29 | 96.98 | 28.2 |
|
5yr Avg ROCE
|
-1.66 % | 33.38 % | 5.33 % |
|
5yr Avg Operating Profit Margin
|
-0.62 % | 11.92 % | 3.77 % |
|
5 yr average Debt to Equity
|
1.24 | 0.04 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | 35.1 % | 0.39 % |
|
5yr Average Return on Assets
|
-2.52 % | 18.77 % | 2.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
15.89 % | 68.96 % | 42.91 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-20.07 % | 0.0 | -6.56 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vineet Laboratories
|
Medistep Healthcare
|
Sandu Pharmaceutical
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|